Cargando…
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
BACKGROUND: Accurately assessing promising therapeutic interventions for human diseases depends, in part, on the reproducibility of preclinical disease models. With the development of transgenic mice, the rapid adaptation of a 6-OHDA mouse model of Parkinson’s disease that was originally described f...
Autores principales: | Rentsch, Peggy, Stayte, Sandy, Morris, Gary P., Vissel, Bryce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374903/ https://www.ncbi.nlm.nih.gov/pubmed/30760214 http://dx.doi.org/10.1186/s12868-019-0487-7 |
Ejemplares similares
-
Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson’s Disease
por: Stayte, Sandy, et al.
Publicado: (2015) -
Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo
por: Stayte, Sandy, et al.
Publicado: (2017) -
Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014) -
Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014) -
New hope for devastating neurodegenerative disease
por: Stayte, Sandy, et al.
Publicado: (2017)